{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:39:58Z","timestamp":1792586398302,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1S81522N"],"award-info":[{"award-number":["1S81522N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G069419N"],"award-info":[{"award-number":["G069419N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds","doi-asserted-by":"publisher","award":["01J15517"],"award-info":[{"award-number":["01J15517"]}],"id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["ZIA 000523-13"],"award-info":[{"award-number":["ZIA 000523-13"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005289","name":"National Institute of Justice","doi-asserted-by":"publisher","award":["2020-DQ-BX-0007"],"award-info":[{"award-number":["2020-DQ-BX-0007"]}],"id":[{"id":"10.13039\/100005289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00204-022-03276-4","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T04:45:00Z","timestamp":1651121100000},"page":"1845-1863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole \u2018nitazene\u2019 synthetic opioid"],"prefix":"10.1007","volume":"96","author":[{"given":"Marthe M.","family":"Vandeputte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Krotulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant C.","family":"Glatfelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Papsun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry K.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-348X","authenticated-orcid":false,"given":"Christophe P.","family":"Stove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"3276_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev.pa.28.040188.002241","volume":"28","author":"MW Adler","year":"1988","unstructured":"Adler MW, Geller EB, Rosow CE, Cochin J (1988) The opioid system and temperature regulation. Annu Rev Pharmacol Toxicol 28:429\u2013449. https:\/\/doi.org\/10.1146\/annurev.pa.28.040188.002241","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3276_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30218-4","volume":"6","author":"Y Bao","year":"2019","unstructured":"Bao Y, Meng S, Shi J, Lu L (2019) Control of fentanyl-related substances in China. The Lancet Psychiatry 6:e15. https:\/\/doi.org\/10.1016\/S2215-0366(19)30218-4","journal-title":"The Lancet Psychiatry"},{"key":"3276_CR33","unstructured":"Belgisch S (2022) Koninklijk besluit tot wijziging van het koninklijk besluit van 6 september 2017 houdende regeling van verdovende middelen en psychotrope stoffen"},{"key":"3276_CR4","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1007\/s00213-021-05981-x","volume":"238","author":"MS-S Bergh","year":"2021","unstructured":"Bergh MS-S, Bogen IL, Garibay N, Baumann MH (2021) Pharmacokinetics and pharmacodynamics of cyclopropylfentanyl in male rats. Psychopharmacology 238:3629\u20133641. https:\/\/doi.org\/10.1007\/s00213-021-05981-x","journal-title":"Psychopharmacology"},{"key":"3276_CR5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/dta.2738","volume":"12","author":"P Blanckaert","year":"2020","unstructured":"Blanckaert P, Cannaert A, Van Uytfanghe K et al (2020) Report on a novel emerging class of highly potent benzimidazole NPS opioids: Chemical and in vitro functional characterization of isotonitazene. Drug Test Anal 12:422\u2013430. https:\/\/doi.org\/10.1002\/dta.2738","journal-title":"Drug Test Anal"},{"key":"3276_CR1","doi-asserted-by":"crossref","unstructured":"Blanckaert P, Balcaen M, Vanhee C, et al (2021) Analytical characterization of \u201cetonitazepyne,\u201d a new pyrrolidinyl\u2010containing 2\u2010benzylbenzimidazole opioid sold online. Drug Test Anal 1\u20138. https:\/\/doi.org\/10.1002\/dta.3113","DOI":"10.1002\/dta.3113"},{"key":"3276_CR6","first-page":"321","volume":"28","author":"M Bucha","year":"2018","unstructured":"Bucha M, Eppakayala L, Maringanti TC (2018) A facile synthesis and molecular docking for anti-inflammatory activity of 2-(4-chlorobenzyl)-1-(2-(pyrrolidin-1-yl) ethyl)-1H-benzo [d] imidazol-5-amine and 2-(4-Chlorobenzyl)-1-((1-ethylpyrrolidin-2-yl) methyl)-1H-benzo [d] imidazol-5-amine. Indian J Heterocycl Chem 28:321\u2013327","journal-title":"Indian J Heterocycl Chem"},{"key":"3276_CR7","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1373\/clinchem.2019.309443","volume":"65","author":"A Cannaert","year":"2019","unstructured":"Cannaert A, Deventer M, Fogarty M et al (2019) Hide and seek: overcoming the masking effect of opioid antagonists in activity-based screening tests. Clin Chem 65:1604\u20131605. https:\/\/doi.org\/10.1373\/clinchem.2019.309443","journal-title":"Clin Chem"},{"key":"3276_CR25","unstructured":"DEA (2021) 21 CFR Part 1308. Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino Etonitazene, and Protonitazene in Schedule I"},{"key":"3276_CR8","volume-title":"Report on the risk assessment of N, N-diethyl-2- [[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1Hbenzimidazole- 1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920\/2006 (as amended)","author":"EMCDDA","year":"2020","unstructured":"EMCDDA (2020) Report on the risk assessment of N, N-diethyl-2- [[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1Hbenzimidazole- 1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920\/2006 (as amended). Publications Office, Luxembourg"},{"key":"3276_CR9","volume-title":"European drug report 2021: trends and developments","author":"EMCDDA","year":"2021","unstructured":"EMCDDA (2021) European drug report 2021: trends and developments. Publications Office of the European Union, Luxembourg"},{"key":"3276_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-022-03257-7","author":"MF Fogarty","year":"2022","unstructured":"Fogarty MF, Vandeputte MM, Krotulski AJ, Papsun D, Walton SE, Stove CP, Logan BK (2022) Toxicological and pharmacological characterization of novel cinnamylpiperazine synthetic opioids in humans and in vitro including 2-methyl AP-237 and AP-238. Arch Toxicol. https:\/\/doi.org\/10.1007\/s00204-022-03257-7","journal-title":"Arch Toxicol"},{"key":"3276_CR10","first-page":"391","volume":"225","author":"EB Geller","year":"1983","unstructured":"Geller EB, Hawk C, Keinath SH et al (1983) Subclasses of opioids based on body temperature change in rats: acute subcutaneous administration. J Pharmacol Exp Ther 225:391\u2013398","journal-title":"J Pharmacol Exp Ther"},{"key":"3276_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/BF02161117","volume":"13","author":"F Gross","year":"1957","unstructured":"Gross F, Turrian H (1957) \u00dcber Benzimidazolderivate mit starker analgetischer Wirkung. Experientia 13:401\u2013403. https:\/\/doi.org\/10.1007\/BF02161117","journal-title":"Experientia"},{"key":"3276_CR12","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/BF02161116","volume":"13","author":"A Hunger","year":"1957","unstructured":"Hunger A, Kebrle J, Rossi A, Hoffmann K (1957) Synthese basisch substituierter, analgetisch wirksamer Benzimidazol-Derivate. Experientia 13:400\u2013401. https:\/\/doi.org\/10.1007\/BF02161116","journal-title":"Experientia"},{"key":"3276_CR13","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/hlca.19600430412","volume":"43","author":"A Hunger","year":"1960","unstructured":"Hunger A, Kebrle J, Rossi A, Hoffmann K (1960a) Benzimidazol-Derivate und verwandte Heterocyclen III. Synthese von 1-Aminoalkyl-2-benzyl-nitro-benzimidazolen. Helv Chim Acta 43:1032\u20131046. https:\/\/doi.org\/10.1002\/hlca.19600430412","journal-title":"Helv Chim Acta"},{"key":"3276_CR14","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/hlca.19600430323","volume":"43","author":"A Hunger","year":"1960","unstructured":"Hunger A, Kebrle J, Rossi A, Hoffmann K (1960b) Benzimidazol-Derivate und verwandte Heterocyclen II. Synthese von 1-Aminoalkyl-2-benzyl-benzimidazolen. Helv Chim Acta 43:800\u2013809. https:\/\/doi.org\/10.1002\/hlca.19600430323","journal-title":"Helv Chim Acta"},{"key":"3276_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/jat\/bkaa016","volume":"44","author":"AJ Krotulski","year":"2020","unstructured":"Krotulski AJ, Papsun DM, Kacinko SL, Logan BK (2020a) Isotonitazene quantitation and metabolite discovery in authentic forensic casework. J Anal Toxicol 44:521\u2013530. https:\/\/doi.org\/10.1093\/jat\/bkaa016","journal-title":"J Anal Toxicol"},{"key":"3276_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/1556-4029.14623","volume":"66","author":"AJ Krotulski","year":"2020","unstructured":"Krotulski AJ, Papsun DM, Noble C et al (2020b) Brorphine\u2014Investigation and quantitation of a new potent synthetic opioid in forensic toxicology casework using liquid chromatography-mass spectrometry. J Forensic Sci 66:664\u2013676. https:\/\/doi.org\/10.1111\/1556-4029.14623","journal-title":"J Forensic Sci"},{"key":"3276_CR17","unstructured":"Krotulski AJ, Manini A, Calello D, et al (2021a) N-piperidinyl etonitazene. https:\/\/www.npsdiscovery.org\/wp-content\/uploads\/2021a\/11\/N-Piperidinyl-Etonitazene_112221_ToxicologyAnalyticalReport.pdf?mc_cid=09d08f4c2f&mc_eid=UNIQID"},{"key":"3276_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/jat\/bkaa113","volume":"45","author":"AJ Krotulski","year":"2021","unstructured":"Krotulski AJ, Papsun DM, Chronister CW et al (2021b) Eutylone intoxications\u2014an emerging synthetic stimulant in forensic investigations. J Anal Toxicol 45:8\u201320. https:\/\/doi.org\/10.1093\/jat\/bkaa113","journal-title":"J Anal Toxicol"},{"key":"3276_CR19","unstructured":"Krotulski AJ, Papsun DM, Fogarty MF, Logan BK (2021c) NPS Discovery: Year in Review 2021. https:\/\/www.drugsandalcohol.ie\/35440\/1\/2021c_Year-In-Review_NPS-Discovery.pdf"},{"key":"3276_CR20","unstructured":"Krotulski AJ, Papsun DM, Walton SE, Logan BK (2021d) New high potency synthetic opioid N-pyrrolidino etonitazene (etonitazepyne) linked to overdoses across United States. https:\/\/www.npsdiscovery.org\/wp-content\/uploads\/2021\/06\/Public-Alert_N-Pyrrolidino-Etonitazene_NPS-Discovery_061721.pdf"},{"key":"3276_CR21","doi-asserted-by":"publisher","unstructured":"Krotulski AJ, Papsun DM, Walton SE, Logan BK (2021e) Metonitazene in the United States\u2014Forensic toxicology assessment of a potent new synthetic opioid using liquid chromatography mass spectrometry. Drug Test Anal 1\u201315. https:\/\/doi.org\/10.1002\/dta.3115","DOI":"10.1002\/dta.3115"},{"key":"3276_CR22","unstructured":"Krotulski AJ, Walton SE, Mohr ALA, Logan BK (2021f) Trend Report Q3 2021: NPS opioids in the United States. https:\/\/www.npsdiscovery.org\/wp-content\/uploads\/2021f\/10\/2021f-Q3_NPS-Opioids_Trend-Report.pdf. Accessed 13 Oct 2021"},{"key":"3276_CR23","unstructured":"Krotulski AJ, Walton SE, Papsun DM et al (2021g) N-pyrrolidino etonitazene. https:\/\/www.npsdiscovery.org\/wp-content\/uploads\/2021g\/05\/N-Pyrrolidino-Etonitazene_051321_ToxicologyAnalyticalReport.pdf"},{"key":"3276_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/jat\/bkaa070","volume":"45","author":"DM Papsun","year":"2021","unstructured":"Papsun DM, Krotulski AJ, Homan J et al (2021) Flualprazolam blood concentrations in 197 Forensic Investigation Cases. J Anal Toxicol 45:226\u2013232. https:\/\/doi.org\/10.1093\/jat\/bkaa070","journal-title":"J Anal Toxicol"},{"key":"3276_CR27","doi-asserted-by":"publisher","unstructured":"Pottie E, Dedecker P, Stove CP (2020a) Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT2AR through simultaneous use of \u03b2-arrestin 2 and miniG\u03b1q bioassays. Biochemical Pharmacology 114251. https:\/\/doi.org\/10.1016\/j.bcp.2020.114251","DOI":"10.1016\/j.bcp.2020.114251"},{"key":"3276_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113934","volume":"177","author":"E Pottie","year":"2020","unstructured":"Pottie E, Tosh DK, Gao Z-G et al (2020b) Assessment of biased agonism at the A3 adenosine receptor using \u03b2-arrestin and miniG\u03b1i recruitment assays. Biochem Pharmacol 177:113934. https:\/\/doi.org\/10.1016\/j.bcp.2020.113934","journal-title":"Biochem Pharmacol"},{"key":"3276_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-0773.1992.tb00441.x","volume":"70","author":"R P\u00f6yhi\u00e4","year":"1992","unstructured":"P\u00f6yhi\u00e4 R, Kalso EA (1992) Antinociceptive effects and central nervous system depression caused by oxycodone and morphine in rats. Pharmacol Toxicol 70:125\u2013130. https:\/\/doi.org\/10.1111\/j.1600-0773.1992.tb00441.x","journal-title":"Pharmacol Toxicol"},{"key":"3276_CR29","doi-asserted-by":"publisher","unstructured":"Pucci M, Hudson S, Hill SL, Thomas SHL (2021) Severe toxicity involving N -pyrrolidino etonitazene in the United Kingdom\u2014a case report. Clinical Toxicology 1\u20132. https:\/\/doi.org\/10.1080\/15563650.2021.1979235","DOI":"10.1080\/15563650.2021.1979235"},{"key":"3276_CR30","doi-asserted-by":"publisher","first-page":"822","DOI":"10.2741\/s190","volume":"S3","author":"SM Rawls","year":"2011","unstructured":"Rawls SM, Benamar K (2011) Effects of opioids cannabinoids and vanilloids on body temperature. Front Biosci S3:822\u2013845. https:\/\/doi.org\/10.2741\/s190","journal-title":"Front Biosci"},{"key":"3276_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1248\/yakushi1947.87.3_301","volume":"87","author":"T Seki","year":"1967","unstructured":"Seki T (1967) Studies on 2-benzimidazolethiol derivatives. V: structure-activity relationship on analgesic action of 1-(Dialkylaminoalkyl)-2-(p-ethoxyphenylthio)benzimidazole. Yakugaku Zasshi 87:301\u2013309. https:\/\/doi.org\/10.1248\/yakushi1947.87.3_301","journal-title":"Yakugaku Zasshi"},{"key":"3276_CR32","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1248\/yakushi1947.89.5_617","volume":"89","author":"T Seki","year":"1969","unstructured":"Seki T, Watanabe Y (1969) Studies on 2-benzimidazolethiol derivatives. VI.: synthesis and analgesic effect of 1-(2-Diethylaminoethyl)-2-(p-ethoxyphenylthio)-5-substituted Benzimidazole. Yakugaku Zasshi 89:617\u2013626. https:\/\/doi.org\/10.1248\/yakushi1947.89.5_617","journal-title":"Yakugaku Zasshi"},{"key":"3276_CR34","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1734-1140(09)70083-0","volume":"61","author":"E Taracha","year":"2009","unstructured":"Taracha E, Mierzejewski P, Lehner M et al (2009) Stress-opioid interactions: a comparison of morphine and methadone. Pharmacol Rep 61:424\u2013435. https:\/\/doi.org\/10.1016\/S1734-1140(09)70083-0","journal-title":"Pharmacol Rep"},{"key":"3276_CR35","unstructured":"117th Congress (2021) H.R. 5305\u2014extending government funding and delivering emergency assistance act"},{"key":"3276_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108195","volume":"177","author":"MT Truver","year":"2020","unstructured":"Truver MT, Smith CR, Garibay N et al (2020) Pharmacodynamics and pharmacokinetics of the novel synthetic opioid, U-47700, in male rats. Neuropharmacology 177:108195. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108195","journal-title":"Neuropharmacology"},{"key":"3276_CR37","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1021\/acschemneuro.1c00037","volume":"12","author":"I Ujv\u00e1ry","year":"2021","unstructured":"Ujv\u00e1ry I, Christie R, Evans-Brown M et al (2021) DARK classics in chemical neuroscience: etonitazene and related benzimidazoles. ACS Chem Neurosci 12:1072\u20131092. https:\/\/doi.org\/10.1021\/acschemneuro.1c00037","journal-title":"ACS Chem Neurosci"},{"key":"3276_CR38","unstructured":"UNODC (1975) The international drug control conventions: schedules of the single convention on narcotic drugs of 1961, as amended by the 1972 Protocol"},{"key":"3276_CR39","unstructured":"UNODC (2020) The growing complexity of the opioid crisis. Global SMART Update, Volume 24. Vienna"},{"key":"3276_CR40","unstructured":"UNODC (2021) Booklet 2: Global overview of drug demand and drug supply. In: World Drug Report 2021. United Nations publication, Vienna, Austria, p 38"},{"key":"3276_CR42","doi-asserted-by":"publisher","unstructured":"Vandeputte MM, Krotulski AJ, Papsun DM et al (2021a) The rise and fall of isotonitazene and brorphine: two recent stars in the synthetic opioid firmament. J Anal Toxicol. https:\/\/doi.org\/10.1093\/jat\/bkab082","DOI":"10.1093\/jat\/bkab082"},{"key":"3276_CR41","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1021\/acschemneuro.1c00064","volume":"12","author":"MM Vandeputte","year":"2021","unstructured":"Vandeputte MM, Van Uytfanghe K, Layle NK et al (2021b) Synthesis, chemical characterization, and \u03bc-opioid receptor activity assessment of the emerging group of \u201cnitazene\u201d 2-benzylbenzimidazole synthetic opioids. ACS Chem Neurosci 12:1241\u20131251. https:\/\/doi.org\/10.1021\/acschemneuro.1c00064","journal-title":"ACS Chem Neurosci"},{"key":"3276_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113910","volume":"177","author":"L Vasudevan","year":"2020","unstructured":"Vasudevan L, Vandeputte MM, Deventer M et al (2020) Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform. Biochem Pharmacol 177:113910. https:\/\/doi.org\/10.1016\/j.bcp.2020.113910","journal-title":"Biochem Pharmacol"},{"key":"3276_CR500","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-022-03294-2","author":"Marthe M Vandeputte","year":"2022","unstructured":"Vandeputte MM, Verougstraete N, Walther D, Glatfelter GC, Malfliet J, Baumann MH, Verstraete AG, Stove CP (2022) First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass. Arch Toxicol. https:\/\/doi.org\/10.1007\/s00204-022-03294-2","journal-title":"Archives of Toxicology"},{"key":"3276_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1124\/pr.112.005942","volume":"65","author":"JT Williams","year":"2013","unstructured":"Williams JT, Ingram SL, Henderson G et al (2013) Regulation of \u00b5 -opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev 65:223\u2013254. https:\/\/doi.org\/10.1124\/pr.112.005942","journal-title":"Pharmacol Rev"},{"key":"3276_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/08958378.2017.1282065","volume":"29","author":"B Wong","year":"2017","unstructured":"Wong B, Perkins MW, Tressler J et al (2017) Effects of inhaled aerosolized carfentanil on real-time physiological responses in mice: a preliminary evaluation of naloxone. Inhalation Toxicol 29:65\u201374. https:\/\/doi.org\/10.1080\/08958378.2017.1282065","journal-title":"Inhalation Toxicol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-022-03276-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-022-03276-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-022-03276-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T18:11:04Z","timestamp":1652292664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-022-03276-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3276"],"URL":"https:\/\/doi.org\/10.1007\/s00204-022-03276-4","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"7 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}